» Articles » PMID: 38449645

CRISPR-like Sequences Association with Antibiotic Resistance and Biofilm Formation in Clinical Isolates

Abstract

Role of clustered regularly interspaced short palindromic repeats (CRISPR)-like sequences in antibiotic resistance and biofilm formation isn't clear. This study investigated association of CRISPR-like sequences with antibiotic resistance and biofilm formation in isolates. Thirty-six of isolates were studied for existence of CRISPR-like sequences using PCR method and their correlation with biofilm formation and antibiotic resistance. Microtiter-plate technique was utilized for investigating antibiotic resistance profile of isolates against amoxicillin, tetracycline, metronidazole and clarithromycin. Biofilm formation of isolates was analyzed by microtiter-plate-based-method. Out of 23 CRISPR-like positive isolates, 19 had ability of biofilm formation and 7 of 13 CRISPR-like negative isolates were able to form biofilm (P = 0.445). In CRISPR-like positive isolates, 11 (48%), 18 (78%), 18 (78%) and 23 (100%) were resistant to amoxicillin, tetracycline, metronidazole and clarithromycin, respectively. Since CRISPR-like sequences have role in antibiotic resistance, may be applied as genetic markers of antibiotic resistance. But there was no substantial correlation between biofilm formation and existence of CRISPR-like sequences. These results indicate possible importance of CRISPR-like sequences on acquisition of resistance to antibiotics in this bacterium.

Citing Articles

Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance.

Kadkhoda H, Gholizadeh P, Kafil H, Ghotaslou R, Pirzadeh T, Rezaee M Heliyon. 2024; 10(14):e34692.

PMID: 39149034 PMC: 11325803. DOI: 10.1016/j.heliyon.2024.e34692.


Prevalence of the CRISPR-cas system and its association with antibiotic resistance in clinical Klebsiella pneumoniae isolates.

Kadkhoda H, Gholizadeh P, Ghotaslou R, Pirzadeh T, Rezaee M, Nabizadeh E BMC Infect Dis. 2024; 24(1):554.

PMID: 38831286 PMC: 11149351. DOI: 10.1186/s12879-024-09451-5.

References
1.
Gholizadeh P, Kose S, Dao S, Ganbarov K, Tanomand A, Dal T . How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance. Infect Drug Resist. 2020; 13:1111-1121. PMC: 7182461. DOI: 10.2147/IDR.S247271. View

2.
Hemmati F, Rezaee M, Ebrahimzadeh S, Yousefi L, Nouri R, Kafil H . Novel Strategies to Combat Bacterial Biofilms. Mol Biotechnol. 2021; 63(7):569-586. DOI: 10.1007/s12033-021-00325-8. View

3.
Foegeding N, Caston R, McClain M, Ohi M, Cover T . An Overview of Helicobacter pylori VacA Toxin Biology. Toxins (Basel). 2016; 8(6). PMC: 4926140. DOI: 10.3390/toxins8060173. View

4.
Kadkhoda H, Ghalavand Z, Nikmanesh B, Kodori M, Houri H, Taghizadeh Maleki D . Characterization of biofilm formation and virulence factors of isolates from paediatric patients in Tehran, Iran. Iran J Basic Med Sci. 2020; 23(5):691-698. PMC: 7374987. DOI: 10.22038/ijbms.2020.36299.8644. View

5.
Kafil H, Mobarez A, Moghadam M . Adhesion and virulence factor properties of Enterococci isolated from clinical samples in Iran. Indian J Pathol Microbiol. 2013; 56(3):238-42. DOI: 10.4103/0377-4929.120375. View